Intake Forms for Rehabilitation and Substance Abuse Treatment: Clinical Assessment, Legal Status, and Recovery Planning
A person presenting at a substance abuse treatment facility is rarely arriving at a calm, considered moment. Some walk in voluntarily after years of escalating consequences. Others are brought in by family members who issued an ultimatum that morning. A significant number arrive directly from a courtroom, a hospital emergency department, or a jail cell — with a judge’s order folded in their pocket and a probation officer expecting compliance reports by Friday. The intake form they encounter in their first hour will shape every clinical decision made on their behalf for weeks or months, yet the circumstances under which they complete it are among the most volatile in all of healthcare documentation.
This tension — between the clinical need for exhaustive information and the practical reality that the person providing it may be intoxicated, in withdrawal, terrified, or coerced — defines substance abuse intake in a way that no other medical specialty quite replicates. A dental patient who leaves mid-intake comes back next month. A rehab patient who walks out during a forty-minute intake questionnaire may not come back at all, and the consequences of that departure can be measured in overdose risk, relapsed sobriety, violated probation, and lost custody.
Substance use history: the clinical foundation
The substance use history is the single most clinically urgent section of a rehab intake because it determines immediate medical decisions. Withdrawal from alcohol and benzodiazepines can be fatal. Withdrawal from opioids is rarely fatal but produces symptoms severe enough to drive patients out of treatment within hours. The intake form needs to capture the specific substances used, the frequency and quantity of use, the route of administration, the duration of the current episode, and — critically — the date and time of last use. A patient who last used alcohol twelve hours ago is in a different medical situation than one who last used it three days ago, and the treatment team cannot wait for a comprehensive psychosocial assessment to make that determination.
Route of administration matters beyond its obvious medical implications. Intravenous drug use carries hepatitis and HIV risk that must be screened immediately. It also signals a level of physiological dependence that oral or nasal use may not, because bioavailability is higher and tolerance escalates faster. Smoking or vaping substances — particularly methamphetamine and fentanyl — has its own clinical profile. The form should capture this detail without euphemism and without judgment, because patients who sense moral assessment in the questions will underreport, and underreporting at intake produces dangerous clinical blind spots.
Polysubstance use complicates every aspect of treatment planning. A patient presenting with alcohol dependence who also uses benzodiazepines recreationally faces a compounded withdrawal risk that neither substance alone would produce. A patient on prescription opioids for chronic pain who also uses cocaine presents a cardiovascular risk profile during withdrawal that demands monitoring. The intake form must accommodate multiple substances with independent fields for each — frequency, quantity, route, duration, last use — rather than a single narrative box that collapses critical distinctions into an unstructured paragraph.
Medical history and co-occurring conditions
Substance abuse rarely travels alone. The concept of dual diagnosis — the co-occurrence of a substance use disorder with one or more psychiatric conditions — is so common in treatment populations that it is closer to the norm than the exception. Depression, anxiety disorders, PTSD, bipolar disorder, and schizophrenia all present at elevated rates in people seeking substance abuse treatment, and each of these conditions changes the treatment plan in material ways. An intake form that captures substance use history without structured psychiatric screening is documenting the symptom while ignoring the substrate.
Medical history in this population carries specific urgencies that a general medical intake may not emphasize. Hepatitis B and C screening status matters because intravenous drug use is the primary transmission vector for hepatitis C in the United States, and a patient’s HCV status affects medication choices throughout treatment. HIV status, and whether the patient is currently on antiretroviral therapy, has direct implications for medication-assisted treatment protocols. Chronic pain — and whether it preceded or followed the substance use — is one of the most clinically consequential questions on the entire form, because pain management during recovery is the single most common trigger for opioid relapse, and the treatment team needs to address it from day one rather than discovering it in week three when the patient starts seeking outside prescriptions.
Pregnancy screening is non-negotiable at intake for patients of childbearing potential. Neonatal abstinence syndrome, the teratogenic effects of certain medications used in treatment, and the vastly different risk calculus of managing withdrawal in a pregnant patient all require immediate identification. Similarly, current medications — prescribed, over-the-counter, and obtained informally — must be documented with enough specificity to prevent dangerous interactions with whatever pharmacological interventions the treatment team initiates.
Previous treatment history: what worked, what failed, and why
A patient’s history of prior treatment attempts is not background information. It is predictive data. The intake form should capture previous rehab admissions, their dates, the level of care (inpatient, outpatient, intensive outpatient, sober living), the length of stay, whether the patient completed the program or left against medical advice, and the patient’s own assessment of why they relapsed. Medication-assisted treatment history is particularly important: whether the patient has previously used methadone, buprenorphine, or naltrexone, how long they maintained the regimen, and what precipitated discontinuation. A patient who was stable on buprenorphine for two years before losing insurance coverage and relapsing is a different clinical profile than one who tried buprenorphine for a week and rejected it.
Twelve-step involvement, SMART Recovery participation, faith-based programs, and other peer support engagement should all be documented. Not to judge their efficacy in the abstract, but because a patient who has attended hundreds of AA meetings and still relapsed is telling you something important about what is and is not working in their recovery ecosystem. The treatment plan needs that information. A structured intake form that asks these questions systematically — rather than hoping they emerge during a clinical interview — ensures they are captured before treatment planning begins. Clinicians looking for structured ways to document psychiatric and therapeutic assessment alongside substance use screening can find purpose-built templates in the healthcare and wellness forms catalog, including dedicated sets for mental health therapy and psychiatry.
Legal and criminal justice involvement
This section of the intake form sits at the intersection of clinical care and legal compliance, and getting it wrong has consequences for the treatment facility, not just the patient. Court-ordered treatment creates a reporting obligation that fundamentally changes the confidentiality framework. Under 42 CFR Part 2, substance abuse treatment records receive stronger federal privacy protections than standard medical records — stricter than HIPAA alone — but those protections have specific exceptions for criminal justice referrals when the patient has signed a qualifying consent. The intake form must document whether the patient is entering treatment voluntarily or under a court order, the specific terms of any judicial mandate, the name and contact information of the referring judge or probation officer, and the scope of information the patient has consented to disclose.
Pending criminal charges are clinically relevant beyond their legal implications. A patient facing a sentencing hearing in six weeks is under a type of stress that affects treatment engagement, relapse risk, and discharge planning. A patient on probation with random drug testing has an external accountability structure that the treatment team can leverage — or that can create perverse incentives if the patient uses the program primarily as a compliance shield rather than a recovery tool. Drug court participation, diversion program enrollment, and parole conditions all need to be documented at intake because they create deadlines, reporting requirements, and constraints on discharge planning that the treatment team must factor into every clinical decision.
The confidentiality tension here is real and must be explained to the patient at intake, not discovered mid-treatment. A patient who believes everything they disclose in treatment is confidential — and then learns their counselor has been sending progress reports to a probation officer — will disengage. The intake form itself should include a clear explanation of what will and will not be disclosed, to whom, and under what circumstances.
Social and family assessment
Substance abuse treatment that ignores the patient’s social environment is treating a person in a vacuum. Housing stability is the most immediate social determinant: a patient who will be discharged to stable housing with a supportive family member has a fundamentally different recovery trajectory than one who will be discharged to a shelter or to the same apartment where they previously used. The intake form needs to capture current housing status, whether the patient has housing to return to after treatment, and whether that housing environment is supportive of or hostile to recovery.
Employment status and employment history affect treatment planning, insurance coverage, discharge timing, and the patient’s sense of identity and purpose in recovery. Family structure — including whether the patient has minor children, who currently has custody of those children, and whether child protective services is involved — is both clinically relevant and legally consequential. Domestic violence screening is essential because intimate partner violence and substance abuse are deeply intertwined, and a patient fleeing an abusive partner has safety needs that override standard discharge protocols. Social support mapping — who in the patient’s life supports their recovery, who actively undermines it, and who is indifferent — gives the treatment team the information it needs to build a discharge plan that survives contact with reality.
Insurance and funding verification
The financial architecture of substance abuse treatment is more complex than most medical billing environments. Patients present with private insurance, Medicaid, Medicare, state block grant funding, SAMHSA discretionary grants, county behavioral health funding, Veterans Affairs coverage, tribal health service eligibility, or no coverage at all. Many facilities operate on a patchwork of these funding streams simultaneously, and the intake form must capture enough information to determine which funding source applies before the patient occupies a bed that might be allocated to a different payer class.
Insurance authorization for substance abuse treatment is notoriously restrictive. Many commercial plans authorize three to five days of residential treatment initially and require clinical justification for continued stay, sometimes on a day-by-day basis. The intake form needs to capture insurance details with enough specificity — policy number, group number, authorization phone number, prior authorization status — to begin the verification process immediately, because a patient whose insurance denies coverage after three days faces an abrupt transition to a lower level of care that may not be clinically appropriate. Sliding-scale eligibility, income documentation requirements, and state-funded treatment slot availability all need to be assessed at intake to avoid mid-treatment funding crises that disrupt recovery.
The intake paradox: thoroughness versus engagement
Every section described above is clinically necessary. Substance use history determines immediate medical management. Medical and psychiatric history shapes the treatment plan. Prior treatment history predicts what will and will not work. Legal status defines reporting obligations. Social assessment drives discharge planning. Insurance verification determines whether treatment can continue past the first week. Omitting any of these sections creates a gap that will surface later, often at the worst possible moment.
And yet the person completing this form may be in acute withdrawal, experiencing their first sober hours in months, terrified of what they have committed to, and acutely sensitive to any signal that the facility views them as a problem rather than a person. A forty-five-minute intake packet administered by a clerk in a fluorescent-lit admissions office, with questions about criminal history and child custody and HIV status presented in rapid succession, can extinguish whatever fragile motivation brought the patient through the door.
The best substance abuse intake forms navigate this tension through structure and sequencing rather than omission. They front-load the medically urgent questions — what did you use, when did you last use, are you currently on any medications — and defer the psychosocial and legal sections to a second session within the first 24 to 48 hours, after the patient has been medically stabilized and has begun to feel safe in the environment. They use language that is clinical without being cold, direct without being judgmental. They separate the questions the admissions staff must ask from the questions the clinical team will explore in the first therapy session. Facilities building or redesigning their intake documentation can find structured healthcare templates in the full forms catalog, where the mental health therapy and psychiatry sets offer models for balancing clinical rigor with patient-centered design.
The goal is not to ask fewer questions. It is to ask the right questions at the right time, in the right order, presented in a way that communicates to the patient — even at their most vulnerable — that the facility is organized, competent, and genuinely interested in their recovery. A well-designed intake form is the first therapeutic intervention, not just the paperwork that precedes it.
Related Forms You Might Need
Mental Health Therapy — $19.99
Psychiatry — $19.99
Occupational Therapy — $19.99
Healthcare intake forms — from $19.99 per complete set
Fillable PDF intake forms and client questionnaires for mental health, psychiatry, therapy, and 18 other healthcare specialties. Built for clinicians managing complex patient populations.
View Healthcare BundleNot ready to buy? Download our free Universal Intake Form — a fillable PDF you can use today, no purchase needed.